Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
about
Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with DysregulationPeptidylarginine Deiminase 3 (PAD3) Is Upregulated by Prolactin Stimulation of CID-9 Cells and Expressed in the Lactating Mouse Mammary GlandWhole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defectsRole of peptidylarginine deiminase 2 (PAD2) in mammary carcinoma cell migrationA FluoPol-ABPP PAD2 high-throughput screen identifies the first calcium site inhibitor targeting the PADs.Expression of Cancer/Testis genes in ductal carcinoma in situ and benign lesions of the breast.Chemical biology of protein arginine modifications in epigenetic regulationThe receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer.Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells.Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice.Protein arginine deiminase 2 binds calcium in an ordered fashion: implications for inhibitor design.Activation of PAD4 in NET formation.Chemical Proteomic Platform To Identify Citrullinated ProteinsDetection and identification of protein citrullination in complex biological systemsProtein Arginine Methylation and Citrullination in Epigenetic RegulationPADI2 gene confers susceptibility to breast cancer and plays tumorigenic role via ACSL4, BINC3 and CA9 signalingCELF1 is a central node in post-transcriptional regulatory programmes underlying EMTRisk analysis of colorectal cancer incidence by gene expression analysis.Investigating the expression, effect and tumorigenic pathway of PADI2 in tumors.Chemical and biological methods to detect post-translational modifications of arginine.Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivationA novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy.Mechanistic studies of protein arginine deiminase 2: evidence for a substrate-assisted mechanismA novel role for protein arginine deiminase 4 in pluripotency: the emerging role of citrullinated histone H1 in cellular programming.PAD1 promotes epithelial-mesenchymal transition and metastasis in triple-negative breast cancer cells by regulating MEK1-ERK1/2-MMP2 signaling.A cellular model reflecting the phenotypic heterogeneity of mutant HRAS driven squamous cell carcinoma.Citrullination/Methylation Crosstalk on Histone H3 Regulates ER-Target Gene Transcription.Design, synthesis, and biological evaluation of tetrazole analogs of Cl-amidine as protein arginine deiminase inhibitors.PAD2 Activity Monitored via a Fluorescent Substrate Analog.Peptidylarginine Deiminases-Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release?Eugenol alleviated breast precancerous lesions through HER2/PI3K-AKT pathway-induced cell apoptosis and S-phase arrest.The lncRNA HOXA11-AS functions as a competing endogenous RNA to regulate PADI2 expression by sponging miR-125a-5p in liver metastasis of colorectal cancer.Human Deiminases: Isoforms, Substrate Specificities, Kinetics, and Detection.Development of a Selective Inhibitor of Protein Arginine Deiminase 2.The Development of Benzimidazole-Based Clickable Probes for the Efficient Labeling of Cellular Protein Arginine Deiminases (PADs).BB-Cl-Amidine as a novel therapeutic for canine and feline mammary cancer via activation of the endoplasmic reticulum stress pathway.Peptidyl arginine deiminase 2 (Padi2) is expressed in Sertoli cells in a specific manner and regulated by SOX9 during testicular development
P2860
Q27001595-6939BB6E-536A-452E-ADCC-DB357CA71B9BQ28552756-2A06A5DC-73C8-45F4-9D97-86DE5825802EQ33434291-B81986FA-18AE-45C7-84A6-8E7A08A3549EQ33733519-627D07CA-B40F-4E69-80CD-DA4A5881FB14Q33939476-9E1CDA0C-5FB9-46D1-823C-D99C432AF14BQ34971907-1E78E475-11C9-4921-BB23-0C614C806202Q35722457-E5D5B13E-0E2A-49F7-A043-43FD0770E3F8Q35752134-9A7280E3-4691-4916-8DC1-6AA1FF2C7D54Q35975093-7EEF6180-3AB8-4535-801F-7A502368C3FBQ36010142-C4B83107-1C3E-4CA4-93A8-4CA9E5CED493Q36057948-DBB66C4D-4095-4A28-80B0-75E48C00D999Q36474561-6396AD7F-9CF5-4873-B8F1-9C07270646E2Q36509456-0FA4D8A7-A9BB-4CA7-AB6D-080A4089FB89Q36515404-0B1EC48E-12D9-447A-ACF0-231AE161AA20Q36713555-5B83BAE0-1612-444F-991A-136CB6C4645BQ37138400-43CE85C1-F28F-4B5B-83B9-3FB0E50EE41DQ37434173-97F5C35C-0FC6-481E-BA62-991F2C281519Q37649691-2D314FDD-ED3B-43EC-8A68-4F4F7EC4DBACQ37702425-C729AE66-F730-4773-992B-35440684EDB3Q38098140-B4FEA53A-F54B-435F-8802-FAD0B11F8CB9Q38280544-7584A4FE-6E04-4CF7-8F2F-A7EFE59B9D76Q38443364-0BD4CFC5-AF2C-4588-8A1F-A0535BA1509FQ38448551-1841AD86-8889-4B8B-B910-97A9D2644749Q38449033-8C513713-769B-444E-B8A9-6132B3EACBC5Q38606630-BBEB1312-DD43-4389-A025-3EEB02686A61Q38778567-82ECD3DC-1CCC-450A-9CA6-4F7329894ED9Q38796261-4EA8B5A4-1996-49B9-AE6F-3B2A206E5C76Q38923181-AAC6DC00-61C5-486A-B244-981746B1F4D6Q39044218-C631ECD6-DF40-418F-8005-B301426A9FD9Q39354673-5143472F-23F0-425F-A00B-7323EFF1B32CQ41346977-345CBA28-7F28-4026-9FA6-5972AC7D6DBFQ42378461-5A4DE386-FE21-40F9-9421-67510F6D174BQ48005731-B2232040-E1E0-498F-8CD3-18B7F5F2DB6AQ48092659-F6C333ED-27C4-4961-93A7-D1D6E9FEE784Q48227505-DC0C6B80-DAEE-4028-821A-E7EDFE7F6092Q52591426-8E28F5FE-667F-4433-8EB3-75B2AF2A98DAQ58763492-0B73C1C7-637C-4658-95DF-5E1579853EFF
P2860
Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
@ast
Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
@en
Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
@en-gb
Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
@nl
type
label
Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
@ast
Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
@en
Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
@en-gb
Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
@nl
prefLabel
Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
@ast
Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
@en
Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
@en-gb
Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
@nl
P2093
P2860
P50
P356
P1433
P1476
Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
@en
P2093
Ashley M Palmer
Corey P Causey
Heike C Breuer
Joe W Gray
Lynne J Anguish
Paul R Thompson
Scott A Coonrod
Sunish Mohanan
P2860
P2888
P356
10.1186/1471-2407-12-500
P407
P577
2012-10-30T00:00:00Z
P5875
P6179
1039446112